Targeting EGFR and uPAR on human rhabdomyosarcoma, osteosarcoma, and ovarian adenocarcinoma with a bispecific ligand-directed toxin

Targeting EGFR and uPAR on human rhabdomyosarcoma, osteosarcoma, and ovarian adenocarcinoma with a bispecific ligand-directed toxin

Felix Oh,1 Deborah Todhunter,1 Elizabeth Taras,1 Daniel A Vallera,1,2 Antonella Borgatti2,3 1Department of Therapeutic Radiology-Radiation Oncology, Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA; 2Animal Cancer Care and Research (ACCR) Program, University of Minnesota, St. Pau...

Full description

Bibliographic Details
Main Authors: Oh F, Todhunter D, Taras E, Vallera DA, Borgatti A
Format: Article
Language:English
Published: Dove Medical Press 2018-09-01
Series:Clinical Pharmacology : Advances and Applications
Subjects:
Sarcoma
carcinoma
eBAT
EGFR
uPAR
Online Access:https://www.dovepress.com/targeting-egfr-and-upar-on-human-rhabdomyosarcoma-osteosarcoma-and-ova-peer-reviewed-article-CPAA

Internet

https://www.dovepress.com/targeting-egfr-and-upar-on-human-rhabdomyosarcoma-osteosarcoma-and-ova-peer-reviewed-article-CPAA

Similar Items